TREA

79206144 - DRAINAD

Follow

Information

  • Trademark
  • 79206144
  • Serial Number
    79206144
  • Registration Number
    5409575
  • Filing Date
    September 30, 2016
    8 years ago
  • Registration Date
    February 27, 2018
    6 years ago
  • Transaction Date
    September 14, 2024
    19 days ago
  • Status Date
    September 13, 2024
    20 days ago
  • Published for Opposition Date
    December 12, 2017
    6 years ago
  • Location Date
    February 27, 2018
    6 years ago
  • Status Code
    709
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    O'BRIEN, JENNIFER
  • Attorney Docket Number
    61459.4001
    Law Office Assigned Location Code
    N20
  • Owners
Information
Mark Drawing Code
4
Mark Identification
DRAINAD
Case File Statements
  • GS0051: Biochemical and chemical preparations for medical purposes in particular those with the active ingredient thiethylperazine, for use in neurodegenerative diseases; biochemical and chemical preparations for medical purposes in particular those with the active ingredient thiethylperazine, for use in dementia disorders and their earlier stages, in particular for use in Alzheimer's disease and mild cognitive impairment; biochemical and chemical preparations for medical purposes, in particular those with the active ingredient thiethylperazine, for prevention against neurodegenerative diseases; biochemical and chemical preparations for medical purposes, in particular those with the active ingredient thiethylperazine, for preventing dementia disorders and their earlier stages, in particular for preventing Alzheimer's disease and mild cognitive impairment; biochemical and chemical preparations for medical purposes, in particular those with the active ingredient thiethylperazine, for the treatment of neurodegenerative diseases; biochemical and chemical preparations for medical purposes in oral administration forms, namely, pills, tablets, dragées, capsules, liquids, drops, in particular including as active ingredient thiethylperazine, for the prevention and/or treatment of neurodegenerative diseases; biochemical and chemical preparations for medical purposes in oral administration form, namely, pills, tablets, dragées, capsules, liquids, drops, in particular including as active ingredient thiethylperazine, for the prevention and/or treatment of Alzheimer's disease and mild cognitive impairment; biochemical and chemical preparations for medical purposes, in particular those with the active ingredient thiethylperazine, for the treatment of dementia disorders and their earlier stages, in particular for the treatment of Alzheimer's disease and mild cognitive impairment; biochemical and chemical preparations for medical purposes in parenteral administration form, namely, injection solutions and infusion solutions, in particular including as active ingredient thiethylperazine, for the prevention and/or treatment of neurodegenerative diseases; biochemical and chemical preparations for medical purposes in parenteral administration forms, namely, injection solutions and infusion solutions, in particular including as active ingredient thiethylperazine, for the prevention and/or treatment of Alzheimer's disease and mild cognitive impairment
  • PM0001: DRAIN AD
  • GS0011: Chemical products for the production of viral, retroviral and non-viral vectors
Case File Event Statements
  • 5/6/2017 - 7 years ago
    4 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 9/29/2017 - 7 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 4/27/2017 - 7 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 5/2/2017 - 7 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 5/2/2017 - 7 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 5/9/2017 - 7 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 5/10/2017 - 7 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 5/18/2017 - 7 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 5/18/2017 - 7 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 6/3/2017 - 7 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 11/22/2017 - 6 years ago
    15 - NOTICE OF PUBLICATION Type: NPUB
  • 11/22/2017 - 6 years ago
    16 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 11/22/2017 - 6 years ago
    17 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 2/21/2018 - 6 years ago
    20 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 10/12/2017 - 6 years ago
    11 - ASSIGNED TO LIE Type: ALIE
  • 10/20/2017 - 6 years ago
    12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 10/20/2017 - 6 years ago
    13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 11/3/2017 - 6 years ago
    14 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 12/8/2017 - 6 years ago
    18 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 12/12/2017 - 6 years ago
    19 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 2/27/2018 - 6 years ago
    21 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 5/27/2018 - 6 years ago
    22 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 6/4/2018 - 6 years ago
    23 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 6/29/2018 - 6 years ago
    25 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 6/4/2018 - 6 years ago
    24 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 7/26/2019 - 5 years ago
    26 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 10/20/2021 - 2 years ago
    27 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 3/11/2022 - 2 years ago
    28 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH
  • 2/27/2023 - a year ago
    29 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Type: REM3
  • 9/13/2024 - 20 days ago
    30 - CANCELLED SECTION 71 Type: C71T